Decision regret after external beam radiotherapy and high dose-rate brachytherapy boost for prostate cancer
World Journal of Urology · 2025
DOI: 10.1007/s00345-025-05615-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, 2025. Verfasst von Lars Haack und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str.3, 24105, Kiel, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Brachytherapy, Decision Making, Emotions. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Schleswig-Holstein - Campus Kiel.
Abstract (Originalsprache)
Purpose
Patients with localized prostate cancer have various treatment options. Decision regret from a patient’s view is an unpleasant feeling concerning a decision in health care. We aimed to explore regret and its determinants after external beam radiotherapy (EBRT) with a high dose-rate brachytherapy (HDR-BT) boost as traditional method of treatment intensification.
Methods
We conducted a secondary analysis of a cross-sectional study. Patients were enrolled at least two years after EBRT + HDR-BT. Decision regret was measured using the Decision Regret Scale (0–100). Covariables included patient characteristics, dose to organs at risk and patient-reported outcomes (PRO) including EPIC- 26, EORTC QLQ-C30, and PSCC. We used Pearson’s correlation and one-way ANOVA analyses.
Results
Among 108 patients, the median age was 73 and the median interval since treatment was 4 years. The mean score of decision regret was 11 (SD: 14). No (0), mild (1–25), or strong (> 25) decision regret was present in 49% (53/108), 39% (42/108), and 12% (13/108) of the patients, respectively. PRO were associated with stronger decision regret including worse urinary incontinence (r = − 0.198; p = 0.046), worse urinary irritative/obstructive symptoms (r = − 0.203; p = 0.045), worse bowel function (r = − 0.312; p = 0.001), worse hormonal function (r = − 0.289; p = 0.003), lower levels of shared-decision making (r = − 0.292; p = 0.002), and lower patient satisfaction (r = − 0.326; p < 0.001).
Conclusion
Long-term decision regret is mild among patients with prostate cancer treated with EBRT + HDR-BT. PRO were associated with decision regret which should be respected in clinical practice.
Trial registration
The study protocol was registered prior to patient accrual on the Open Science Framework (doi.org/10.17605/OSF.IO/A6DC3).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str.3, 24105, Kiel, Germany.
- Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Urology, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.
- URODOCK Urology Group Practice, Kiel, Germany.
- Department of Radiation Oncology, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str.3, 24105, Kiel, Germany. alexander.fabian@uksh.de.
Förderung
- Universitätsklinikum Schleswig-Holstein - Campus Kiel
Zitieren
APA
Haack, L., Krug, D., Rodler, S., Nuhn, P., van der Horst, C., Schulz, C., Wittenstein, O., Schmalz, C., Blanck, O., Siebert, F. A., & Fabian, A. (2025). Decision regret after external beam radiotherapy and high dose-rate brachytherapy boost for prostate cancer. World Journal of Urology. https://doi.org/10.1007/s00345-025-05615-3
Vancouver
Haack L, Krug D, Rodler S, Nuhn P, van der Horst C, Schulz C, et al. Decision regret after external beam radiotherapy and high dose-rate brachytherapy boost for prostate cancer. World Journal of Urology. 2025. doi:10.1007/s00345-025-05615-3
BibTeX
@article{Haack2025,
author = {Haack, Lars and Krug, David and Rodler, Severin and Nuhn, Philipp and van der Horst, Christof and Schulz, Christian and Wittenstein, Olaf and Schmalz, Claudia and Blanck, Oliver and Siebert, Frank-André and Fabian, Alexander},
title = {Decision regret after external beam radiotherapy and high dose-rate brachytherapy boost for prostate cancer},
journal = {World Journal of Urology},
year = {2025},
doi = {10.1007/s00345-025-05615-3}
}
EUVIMED